ライフサイエンスコーパス: wound complication

1 Bacterial biofilms represent a major wound complication.

2 that is of particular relevance to diabetic wound complication.

3 sociated with an increased risk of abdominal wound complication.

4 6 months in mean WBC, HgB, or platelets, or wound complications.

5 ses were performed to identify predictors of wound complications.

6 creases the incidence of ischemic events and wound complications.

7 The primary outcome measure was surgical wound complications.

8 urgical dissection required often results in wound complications.

9 al disability and increase the likelihood of wound complications.

10 as been anecdotally associated with surgical wound complications.

11 n technical losses or in posttransplantation wound complications.

12 remity tumors were associated with increased wound complications.

13 omplications were wound infections and other wound complications.

14 -spinal joints, worsening of myelopathy, and wound complications.

15 , effective, and decreases hospital stay and wound complications.

16 echnical considerations designed to minimize wound complications.

17 have favored submuscular insertion to avoid wound complications.

18 or Charlson-Deyo comorbidity score and acute wound complications.

19 n be associated with morbidity, particularly wound complications.

20 s' risk of surgical site infection and other wound complications.

21 ng surgical site infections (SSIs) and other wound complications.

22 tion is associated with an increased risk of wound complications.

23 llergic contact dermatitis, and incidence of wound complications.

24 included surgical-site infections and other wound complications.

25 omentoplasty for the prevention of perineal wound complications.

26 etic patients despite higher risk of sternal wound complications.

27 sidered in patients at high risk for sternal wound complications.

28 dectomy, parathyroid autotransplantation, or wound complications.

29 atients were recruited; 16 (13.7%) developed wound complications.

30 therapies, and their effect on perioperative wound complications.

31 ed factors that might predispose patients to wound complications.

32 return to full activity and fewer long-term wound complications.

33 s thromboembolism (0.82; 95% CI, 0.81-0.83); wound complications (0.78; 95% CI, 0.78-0.79); 30-day mo

34 ith nonsmokers following open interventions (wound complications: 146 [9.9%] vs 87 [5.8%]; ARD, 4.05%

35 primary nonfunction, 3% vs. 2% (P=0.38); and wound complications, 19% vs. 17% (P=0.54).

36 patients who underwent MIG experienced less wound complications (2% vs 5%, P = 0.006).

37 ow-up of 22.1 (range, 7.67-41.11) months, 29 wound complications (2.53%) had occurred [bleeding 0%/in

38 no significant differences, including other wound complications (2.6% vs 3.1%; difference, -0.53%; 9

39 (7.8% vs. 19.6%, P=0.007), and nonoperative wound complications (2.9% vs. 14.2%, P=0.001).

40 aravalvular leak, 2 patients (11%) had groin wound complications, 2 patients (11%) required a permane

41 1.7%; RR mortality = 2.9; 95% CI = 2.3-3.7), wound complications (21.1%; RR mortality = 0.7; 95% CI =

42 4-6.35), biologic mesh (3.1, 1.67-5.75), and wound complications (3.01, 1.69-5.39) were predictors of

43 Most common readmission reasons were wound complications (30.7%), gastrointestinal (16.1%), b

44 5%, P = 0.26) rates favored LC with perineal wound complications (38.3% vs 50.0%, P = 0.26) in favor

45 rgical site infection (3.2% vs 3.2%, P=.91), wound complication (5.9% vs 6.5%, P=.30), any complicati

46 erence, -6.5% [95% CI, -11.4% to -1.4%]) and wound complications (5.6% vs 16.0%; difference, -11.7% [

47 posite of surgical-site infections and other wound complications (6.5% vs 6.7%; difference, -0.27%; 9

48 occurred in 215 (35.0%) patients, including: wound complications (61, 9.9%), chest infection (50, 8.1

49 eduction (group 2 vs. group 1) in cumulative wound complications (7.8% vs. 19.6%, P=0.007), and nonop

50 ded hypertension (12% v 1.8%, respectively), wound complications (abdominal incisional hernia or infu

51 tcomes included complications (overall acute wound complications, acute surgical site infection [SSI]

52 that is widely used to reduce postoperative wound complications after coronary-artery bypass graftin

53 Postoperative wound complications after excisional surgery for primary

54 Wound complications after IR were associated with signif

55 Outcome measures included wound complication and hernia recurrence.

56 With the exception of superficial wound complications and atrial dysrhythmias, obesity is

57 BMP-2 was associated with increased risk for wound complications and dysphagia.

58 Wound complications and graft failure were higher for sm

59 d models were used to identify predictors of wound complications and hernia recurrence, respectively.

60 of open surgery, such as postoperative pain, wound complications and infections, and prolonged length

61 Morbidity outcomes consisted of wound complications and late toxic effects.

62 idity and mortality comparable with OG, less wound complications and shorter hospitalization.

63 Secondary outcome measures included wound complications and the composite of death, myocardi

64 were detected between patients who developed wound complications and those who did not.

65 d 2.5- to 4.5-fold higher risk of developing wound complications, and a 4-to 8-fold higher risk of de

66 posite of surgical-site infections and other wound complications, and adverse skin reactions.

67 for uterine infection, obstetrical surgical wound complications, and cardiopulmonary and thromboembo

68 y profiles (hospital readmission, infection, wound complications, and metabolic complications).

69 myocardial infarction, dialysis requirement, wound complications, and need for surgical reinterventio

70 postpartum hemorrhage, obstetrical surgical wound complications, and pelvic injury.

71 ncluded demographics, perioperative details, wound complications, and recurrences.

72 The true incidence of postoperative wound complications, and their correlation with closure

73 eloped fistula; nine patients, perioperative wound complications; and four patients, pelvic infection

74 ates of superficial surgical site infection, wound complication, any complication, and 30-day mortali

75 Our hypothesis was that wound complications are related, in part, to the immune

76 ts, 37 (31%, 95% CI 24-40) developed a major wound complication at a median time of 37 days (IQR 25-5

77 g rule simulator comparing the rate of major wound complications at 120 days post-surgery among study

78 The primary endpoints were SSI or other wound complications at 3 months, assessed by wound care

79 in the number of minor, major, or infectious wound complications between the groups.

80 nt characteristics have been associated with wound complications, but there is currently no quantitat

81 deep infection/abscess by 37%, and for minor wound complications by 54%.

82 Secondary outcomes included other wound complications, composite of surgical-site infectio

83 ficial, deep, or organ/body space), rates of wound complications (dehiscence, haematoma, seroma, blee

84 Twenty-four wound complications developed in 18 (46.2%) patients, in

85 mine the incidence of, and risk factors for, wound complications (e.g., infections, hernias) in kidne

86 ent-emergent adverse event was postoperative wound complication (eight [9%] of 89 patients in the NBT

87 Perineal wound complications frequently occur after eAPR with pre

88 toperative complications: general morbidity, wound complications, general infections, pulmonary compl

89 bowel habits or malabsorption; only 1 minor wound complication has occurred.

90 atic colorectal cancer (CRC), an increase in wound complications has been observed in patients who un

91 We studied postoperative surgical wound complications in 15 kidney recipients receiving si

92 The overall incidence of wound complications in our study population was 9.65% (n

93 es may be associated with the higher risk of wound complications in patients who undergo radiotherapy

94 nd was associated with hernia recurrence and wound complications in this population.

95 Predictors of wound complications included ASA score, diabetes, smokin

96 rimary advantage is an extremely low risk of wound complications, including infection and hernia.

97 or subtotal thyroidectomy (p = 0.001) while wound complications increased after radical neck dissect

98 transumbilical SIL surgery, the incidence of wound complications is acceptable low and is further red

99 es, the significantly increased incidence of wound complications leads to the conclusion that ELAPE s

100 e 4 thrombocytopenia and limited increase in wound complications may be observed.

101 Secondary end points included major wound complications (MWC), local failure, distant progre

102 gical site infection (SSI) and noninfectious wound complications (NIWCs) after delayed (DR) and secon

103 Wound complications occurred in 3.9% of the craniotomy g

104 proportion of the craniotomy group, but more wound complications occurred in the craniectomy group.

105 The primary endpoint was a major wound complication occurring within 120 days of surgery.

106 sults in excellent local control, with major wound complications occurring in approximately 35% of pa

107 significantly reduced risk for perioperative wound complications (Odds Ratio 0.400 [95% confidence in

108 ld provide a practical predictive marker for wound complications on which selective antibiotic prophy

109 Patients were classified as having a wound complication or not.

110 s developed postoperative bowel obstruction, wound complications, or anastomotic leaks or died.

111 rol group experienced more than one surgical wound complication (P=0.014), and the relaparotomy incid

112 s a significant and independent predictor of wound complications (P < 0.005 and P < 0.0001,respective

113 The incidence of wound complications, pain, recurrences, and patients dis

114 postoperative morbidity, general infections, wound complications, pulmonary complications, prolonged

115 Likewise, there was no difference in wound complication rate between patients with SDD and th

116 d decreasing the target sirolimus level, the wound complication rate in the sirolimus group was 35% (

117 In the first phase of the study, the wound complication rate in the sirolimus group was 55% (

118 series have raised concerns toward a higher wound complication rate related to the transumbilical in

119 demonstrated a significantly higher surgical wound complication rate, but graft and patient survival

120 ed follow-up, albeit at the cost of a higher wound complication rate.

121 characteristics were associated with higher wound complication rates: diabetes (P = 0.02); larger tu

122 sting was associated with lower harvest site wound complications relative to open vein-graft harvesti

123 sting was associated with lower harvest site wound complications relative to open vein-graft harvesti

124 The rate of wound complication requiring intervention was 17%, and t

125 e mofetil who were pair-matched for surgical wound complication risk factors.

126 l infections (RR = 1.73; 95% CI: 1.32-2.28), wound complications (RR = 1.23; 95% CI: 1.09-1.40), pulm

127 eral morbidity (RR=1.52, 95% CI: 1.33-1.74), wound complications (RR=2.15, 95% CI: 1.87-2.49), genera

128 of iNPWT for the prevention of postoperative wound complications such as SSI.

129 n and a composite including MACE and sternal wound complication (SWC).

130 A laparoscopic approach results in fewer wound complications than an open approach.

131 emoradiotherapy group, n=7), including three wound complications that required surgery (all in the ne

132 ints were bleeding complications and sternal wound complications up to 6 months after surgery.

133 The rate of sternal wound complication was 3.5% in the bilateral-graft group

134 Wound complication was present in 27.3% of patients, wit

135 Although wound complication was the most common reason for readmi

136 Superficial wound complication was the most common wound event, 2.24

137 The incidence of wound complications was 10% and 2 patients required a se

138 x on hematologic grade 3 or 4 toxicities and wound complications was analyzed.

139 The only significant predictors of a wound complication were morbid obesity (BMI >30), having

140 The primary endpoint was any SWI; other wound complications were also analysed.

141 Leg-wound complications were also evaluated.

142 Surgical wound complications were defined as any complication rel

143 Wound complications were defined as drainage, erythema,

144 Major wound complications were defined as those requiring a se

145 stic regression models for the prediction of wound complications were developed.

146 Wound complications were diagnosed within the first 2 po

147 Postoperative wound complications were identified in 61 (47.7%) patien

148 Wound complications were observed in 13.5% of patients:

149 r a minimum of 6 months postoperatively, and wound complications were recorded as bleeding, infection

150 More wound complications were seen in prepatients (25.9% vs 1

151 ease in 30-day hospital readmission rates or wound complications when compared with discharge 1 or 2

152 s requiring biologic mesh were predictors of wound complications, whereas recurrent hernia repair (2.

153 There were more sternal wound complications with bilateral internal-thoracic-art

154 but a significantly lower incidence of total wound complications with intradermal suture closure than

155 g bivariate relationships with postoperative wound complications with P < or = 0.20 were submitted fo

156 f graciloplasty patients experienced a major wound complication, with therapy failing in 41%.